Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000020

Chief Scientific Officer acquired 72,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kishimoto Takashi Kei · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 1 in the form +72,000 271,769 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +340,000 340,000 D
Loading xslF345X03/wf-form4_164141844549022.xml…